Skip to content

Development of an Assessment Tool for Health-related Quality of Life in Children and Adolescents With Pompe Disease

Development and Validation of a Standardized Assessment Instrument for Health-related Quality of Life (HrQoL) in Children and Adolescents With Pompe Disease (PD): a Joint Effort of Patients, Caregivers and Metabolic Experts

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04724213
Acronym
Pompe_HrQol
Enrollment
101
Registered
2021-01-26
Start date
2021-07-01
Completion date
2023-12-01
Last updated
2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pompe Disease

Brief summary

Health related quality of life (HrQoL), is the patient's subjective perception of the impact of his disease and its treatment on his daily life, physical, psychological and social functioning and well-being and thus constitutes a patient reported outcome (PRO) of utmost importance. Generic HrQoL instruments can by definition not capture disease-specific parameters nor are they sensitive enough to detect their changes. In this study, a disease-specific HrQoL questionnaire for children and adolescents will be developed. Patients and parents will be involved in focus groups and interviews to identify relevant contents. The instrument will be tested for validity and reliability.

Interventions

OTHERTesting of reliability / validity of new questionnaire

Participants will answer new questionnaire and other, established, generic and chronic generic HrQol instruments

Sponsors

Sanofi
CollaboratorINDUSTRY
University Children's Hospital, Zurich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with PD from age 8 years * Parent of patient(s) \< 18 years with PD * Able to give informed consent as documented by signature * Sufficient command of the German language

Exclusion criteria

* \- Inability to follow the procedures of the study, e.g. due to language problems or severely reduced health status

Design outcomes

Primary

MeasureTime frame
Reliability/ validity of questionnaire15 months

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026